Finance

Beta
Lists
AGY:LON
Allergy Therapeutics plc
GBX 8.70
0.00%
(0.00) 1D
Jun 4, 9:15:18 AM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for AGY...
Open
GBX 8.90
High
GBX 8.90
Low
GBX 8.50
Mkt. cap
550.93M
Avg. vol.
256.64K
Volume
9.30K
52-wk high
GBX 12.10
52-wk low
GBX 6.50
EPS
-GBX 0.01
Shares outstanding
6.33B
No. of employees
584
Open
GBX 8.90
High
GBX 8.90
Low
GBX 8.50
Mkt. cap
550.93M
Avg. vol.
256.64K
Volume
9.30K
52-wk high
GBX 12.10
52-wk low
GBX 6.50
EPS
-GBX 0.01
Shares outstanding
6.33B
No. of employees
584
News stories
From sources across the web
About Allergy Therapeutics plc
CEOManuel Llobet
Employees584
Founded1998
Headquarters-
SectorPharmaceutical industry
Websiteallergytherapeutics.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
10.51M
10.51M
18.14M
18.14M
Cost of goods sold
6.29M
6.29M
7.40M
7.40M
Cost of revenue
6.29M
6.29M
7.40M
7.40M
Research and development expenses
3.86M
3.86M
4.42M
4.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.47M
9.47M
10.71M
10.71M
Operating expense
15.42M
15.42M
16.43M
16.43M
Total operating expenses
21.71M
21.71M
23.83M
23.83M
Operating income
-11.20M
-11.20M
-5.69M
-5.69M
Other non operating income
-1.32M
-1.32M
-2.08M
-2.08M
EBT including unusual items
-13.92M
-13.92M
-9.66M
-9.66M
EBT excluding unusual items
-14.13M
-14.13M
-9.66M
-9.66M
Income tax expense
604.50K
604.50K
294.00K
294.00K
Effective tax rate
-4.34%
-4.34%
-3.04%
-3.04%
Other operating expenses
-436.50K
-436.50K
-273.00K
-273.00K
Net income
-14.52M
-14.52M
-9.96M
-9.96M
Net profit margin
-138.23%
-138.23%
-54.90%
-54.90%
Earnings per share
-
-
-
-
Interest and investment income
84.50K
84.50K
72.00K
72.00K
Interest expense
-1.70M
-1.70M
-1.97M
-1.97M
Net interest expenses
-1.62M
-1.62M
-1.90M
-1.90M
Depreciation and amortization charges
1.81M
1.81M
1.03M
1.03M
EBITDA
-11.01M
-11.01M
-4.61M
-4.61M
Gain or loss from assets sale
23.00K
23.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer